Literature DB >> 21348388

Presternal catheter design--an opportunity to capitalize on catheter immobilization.

Dale G Zimmerman1.   

Abstract

Effective immobilization of the peritoneal catheter has repeatedly been associated with positive catheter-related outcomes. This single-center retrospective community study compared infectious complication rates for peritoneal catheters that exit from a highly mobile structure (the abdomen) with rates for catheters exiting from a structure with minimal associated motion (the chest). Data were collected between January 1, 2005, and January 31, 2010. Patients undergoing catheter implantation were divided into two groups: 22 patients with 23 abdominal catheters; 21 patients with 22 presternal catheters. The abdominal and presternal groups were similar, with the exception of catheter experience (410.4 months and 187.2 months respectively), and mean body mass index (BMI--26.2 kg/m2 and 29.1 kg/m2 respectively). Catheter-related infections prompted removal of 2 abdominal catheters. No presternal catheters had to be removed. For abdominal and presternal catheters respectively, the rates of exit-site infection were 0.22 episodes/ patient-year and 0.11 episodes/patient-year (p = 0.73), and the incidences of peritonitis were 0.41 episodes/patient-year and 0.27 episodes/patient-year (p = 0.63). The more effective catheter immobilization on the chest may lower the frequency of infectious complications.

Entities:  

Mesh:

Year:  2010        PMID: 21348388

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  3 in total

Review 1.  Peritoneal dialysis associated infections: An update on diagnosis and management.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-08-06

2.  Peritoneal dialysis catheters with back exit sites.

Authors:  Todd Penner; John H Crabtree
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

3.  Extrusion of both Superficial and Deep Cuffs of a Functional Double-Cuff Peritoneal Dialysis Catheter after Significant Weight Loss.

Authors:  Aravindh S Ganapathy; Myron S Powell; James L Pirkle
Journal:  Case Rep Nephrol Dial       Date:  2021-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.